Emmaus Life Sciences, Inc.
EMMA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $1 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $2 | $2 | $3 |
| Inventory | $1 | $1 | $1 | $2 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $5 | $5 | $6 | $7 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $17 | $15 | $15 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15 | $0 | $0 | $0 |
| Total NC Assets | $16 | $18 | $17 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21 | $23 | $22 | $24 |
| Liabilities | – | – | – | – |
| Payables | $0 | $5 | $3 | $3 |
| Short-Term Debt | $28 | $29 | $30 | $30 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $10 | $10 | $10 |
| Other Curr. Liab. | $36 | $19 | $21 | $20 |
| Total Curr. Liab. | $64 | $62 | $65 | $64 |
| LT Debt | $4 | $4 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $12 | $13 | $13 | $13 |
| Total NC Liab. | $16 | $17 | $16 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $2 | $3 | $3 |
| Total Liabilities | $80 | $79 | $81 | $80 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$268 | -$266 | -$265 | -$263 |
| AOCI | -$0 | $1 | -$3 | -$3 |
| Other Equity | $209 | $209 | $209 | $209 |
| Total Equity | -$59 | -$56 | -$59 | -$56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21 | $23 | $22 | $24 |
| Net Debt | $31 | $32 | $32 | $32 |